Ann LaCasce, MD, MMSc, director of the Dana-Farber/Massachusetts General Brigham Fellowship in Hematology/Oncology, highlights the role of bispecific antibodies in lymphoma research.
Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...
After many months, if not years, of leaks and speculation, it’s finally official: Nintendo has announced its next console, and it’s called Nintendo Switch 2. As the name implies, it’s a very ...
A Bangladeshi expatriate died three days after he was beaten for allegedly recording a video of an attack on a Chandpur union Chhatra League leader in Kapasia of Gazipur. The deceased, Enamul ...
BH3 mimetics are small molecules that mimic BH3-only proteins by binding to and inhibiting the prosurvival members of the Bcl-2 family ... (the majority with follicular lymphoma) received ...
He joined The Verge in 2019 after nearly two years at Techmeme. Nintendo shared the first details about the Nintendo Switch 2 in a video published Thursday. Nintendo doesn’t give a specific ...
The Switch 2 has been revealed, and it's coming this year. But Nintendo's not telling us more until April 2. For now, here's the trailer: Yes, there's a new Mario Kart. And yes, this looks a lot ...
Nintendo has unveiled the long-awaited successor to its popular Switch video game console: the Nintendo Switch 2. First-look images at the console design and a teaser trailer were revealed by ...
Nintendo has finally revealed the Switch 2 with a video that confirms a number of new features while sparking burning questions for fans to discuss. While pre-announce leaks proved to be pretty ...
The Nintendo Switch 2 has been confirmed, and we'll find out more about it in a Nintendo Direct focused on the new console that's coming in early April. In a video released a few minutes ago ...
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
The addition of Monjuvi to standard-of-care therapy reduced the risk of disease progression, relapse, or death in patients with relapsed/refractory follicular lymphoma Compared to placebo, the ...